Knowledge and Attitude of Pharmacists about Biosimilar Medications in Saudi Arabia

  • Abdullah Khaloofah Alahmari Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Ziyad Saeed Almalki Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Muhammad Shahid Iqbal Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Manal Abdullah Alossaimi Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, SAUDI ARABIA
  • Mohammed Zaid Alsaber Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Raslan Abdullah Alanazi Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Yazeed Mohammed Alruwaili Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Saad Nashmi Altheiby Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
  • Thekra Omar Bin Salman Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA
Keywords: Pharmacists, Biosimilar medications, Knowledge, Attitude, Saudi Arabia

Abstract

Objectives: This study determined knowledge and attitude of pharmacists about biosimilar mdications in Saudi Arabia. Methods: Pharmacists from different areas and regions were approached to participate in this cross-sectional study. Data were collected by a pre-validated and selfadministered research tool using a convenience sampling technique. Analyses and interpretation of the data were done using descriptive and inferential statistics with Statistical Package for Social Sciences (SPSS) version 24.0. Results: A total of 319 pharmacists from different specialties participated in the study. A total of 111 pharmacists were males, and 208 were females. All of the pharmacists had varied expertise. Around 41.4% of the studied pharmacists were practicing in the community, 34.5% in hospitals and 24.1% were in other areas. Conclusion: This study reported the current level of pharmacists’ knowledge and attitude about biosimilar medications in Saudi Arabia. Statistically, a significant association was observed between male and female pharmacists regarding the introduction of biosimilar medications in the Saudi Arabian healthcare setup.

Downloads

Download data is not yet available.
Demographic characteristics of the study participants (%)
Published
2021-03-31
How to Cite
1.
Khaloofah Alahmari A, Saeed Almalki Z, Shahid Iqbal M, Abdullah Alossaimi M, Zaid Alsaber M, Abdullah Alanazi R, Mohammed Alruwaili Y, Nashmi Altheiby S, Omar Bin Salman T. Knowledge and Attitude of Pharmacists about Biosimilar Medications in Saudi Arabia. ijpi [Internet]. 31Mar.2021 [cited 14May2021];11(1):123-6. Available from: https://www.jpionline.org/index.php/ijpi/article/view/997